Eli Lilly and Co said on Monday it had started an early-stage trial to test its potential treatment for COVID-19, in the world's first study of an antibody treatment against the disease.
- Eli Lilly and Co said on Monday it had started an early-stage trial to test its potential treatment for COVID-19, in the world’s first study of an antibody treatment against the disease.
Lilly is one of the several drugmakers and research institutions that are working on vaccines, antivirals and other treatments to help those infected with the fast-spreading novel coronavirus, which has already killed over 370,000 worldwide. Lilly said its early stage study will assess safety and tolerability in patients hospitalized with COVID-19 and results are anticipated by the end of June.
Lilly’s treatment is an antibody directed against the spike-shaped protein structures of the virus and is designed to block it from locking on to human cells, thus neutralizing the virus.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Eli Lilly starts human study of potential COVID-19 treatmentEli Lilly and Co said on Monday first set of patients have been dosed in an early-stage trial to test its potential treatment for COVID-19, in the world's first study of an antibody treatment against the disease.
続きを読む »
Eli Lilly starts human study of a potential coronavirus treatmentEli Lilly said on Monday patients have been dosed to test its potential antibody treatment designed to fight COVID-19, caused by the new coronavirus.
続きを読む »
Coronavirus live updates: Eli Lilly starts world's first human trial of potential antibody treatmentThe coronavirus has infected more than 6.18 million people around the world as of Monday, killing at least 372,469 people.
続きを読む »
Stocks making the biggest moves in the premarket: Eli Lilly, Coty, Amazon, Zynga, Delta & moreThe stocks making the biggest moves in premarket trading include Eli Lilly, Coty, Amazon, Zynga, Delta, and more.
続きを読む »
Eli Lilly starts human study of potential COVID-19 treatmentEli Lilly and Co said on Monday first set of patients have been dosed in an early-stage trial to test its potential treatment for COVID-19, in the world's first study of an antibody treatment against the disease.
続きを読む »